Work

The Molecular Screening and Therapeutics (MoST) Program: A precision medicine framework for biomarker-driven signal-seeking clinical studies for rare cancers.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps2621

Authors: Dominique Hess, Lucille T Sebastian, Katrin Marie Sjoquist, Chee Khoon Lee, Wendy Hague, Danielle Miller, Mark Cowley, Min Ru Qiu, Stephen B. Fox, Anthony M. Joshua, John Simes, David Morgan Thomas

Institutions: Garvan Institute of Medical Research, The University of Sydney, St Vincent's Hospital Sydney, Peter MacCallum Cancer Centre, The Kinghorn Cancer Centre

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889717089

Cites:

Cited by:

Related to: 10